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RTX toxins (repeats in the structural toxin) are pore-forming protein toxins produced by a
broad range of pathogenic Gram-negative bacteria. In vitro, RTX toxins mostly exhibit a
cytotoxic and often also a hemolytic activity. They are particularly widespread in species of
the family Pasteurellaceae which cause infectious diseases, most frequently in animals but
also in humans. Most RTX toxins are proteins with a molecular mass of 100 ± 200 kDa and
are post-translationally activated by acylation via a specific activator protein. The repeated
structure of RTX toxins, which gave them their name, is composed of iterative glycine-rich
nonapeptides binding Ca2 on the C-terminal half of the protein. Genetic analysis of RTX
toxins of various species of Pasteurellaceae and of a few other Gram-negative bacteria gave
evidence of horizontal transfer of genes encoding RTX toxins and led to speculations that
RTX toxins might have originated from Pasteurellaceae. The toxic activities of RTX toxins
in host cells may lead to necrosis and apoptosis and the underlying detailed mechanisms are
currently under investigation. The impact of RTX toxins in pathogenicity and the immune
responses of the host were described for several species of Pasteurellaceae. Neutralizing
antibodies were shown to significantly reduce the cytotoxic activity of RTX toxins. They
constitute a valuable strategy in the development of immuno-prophylactics against several
animal diseases caused by pathogenic species of Pasteurellaceae. Although many RTX toxins
possess cytotoxic and hemolytic activities toward a broad range of cells and erythrocytes,
respectively, a few RTX toxins were shown to have cytotoxic activity only against cells of
specific hosts and/or show cell-type specificity. Further evidence exists that RTX toxins play
a potential role in host specificity of certain pathogens.
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Bacterial RTX toxins, named by their repeats in the
structural toxin peptide (Strathdee and Lo, 1989),
constitute a homogenous family of pore-forming
toxins of Gram-negative bacteria. The hemolytic
activity is themost obvious phenotype ofmanyRTX
toxins under in vitro conditions. However, the
erythrocytes might not be the main targets of RTX
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toxins. In vivo, RTX toxins induce inflammatory
mediators or exert cytotoxic and cytolytic effects
mainly to cells of the host's immune defense, thus
provoking necrosis, apoptosis, inflammation and
disease (Czuprynski andWelch, 1995;Welch, 2001).
RTX toxins are postulated by some authors to act in
synergy with lipopolysaccharides (Czuprynski and
Welch, 1995; Li and Clinkenbeard, 1999) which is
currently debated (Welch, 2001). RTX toxins are
proteins with a typical molecular mass of 100 ±
200 kDa. The pore forming activity was shown for
several RTX toxins, but was studied in detail mostly
for the Escherichia coli -hemolysin HlyA (Benz
et al., 1992; Benz et al., 1994; Ludwig et al., 1991,
1993; Maier et al., 1996). In contrast to the concept
of pore forming activity of RTX toxins, one study
which was done with the E. coli -hemolysin HlyA
indicated that HlyA is inserted in the target mem-
brane as an integral protein, thus occupying only one
of the membrane phospolipid monolayers, thus
excluding a trans-membrane location which is
incompatible with pore forming activity (Soloaga
et al., 1999). The consensus structure of most RTX
toxins is shown in Figure 1. It shows, at the N-
terminal end, a strong membrane-active amphi-
pathic helix structure presumably initiating the
contact with the host cell, followed by large hydro-
phobic domainswhichwere shown to create pores in
lipid bi-layers (Ludwig et al., 1991, 1993). The
central part of the protein contains one or several
acylation sites characterized by glycine-lysine,
where the lysine residue is acylated post-translation-
ally by means of a specific activator protein C
encodedon the sameoperonas the structural toxinA
(Hughes et al., 1992a; Ludwig et al., 1996; Stanley
et al., 1998). The repeated structure of RTX toxins,
which gave them their name, is constituted by 9 ± 47
copies of iterative glycine-rich nonapeptides on the
C-terminal half of the protein (Fig. 1). These glycine-
rich repeats have a strong capacity to bind Ca2,
which was shown to be involved in binding to
erythrocytes together with the lipidated amino acid
residues (Hughes et al., 1992b; Ludwig et al., 1988).
The 30 ± 50 most C-terminal amino acids of the
structural toxin protein constitute the signal for the
specific type I secretion system which is encoded by
twogenes,B andD, both locatedon the sameoperon
as the activator geneC, and the structural toxin gene
A, organized in the manner CABD (Hughes et al.,
1992b) (Fig. 1). Probably due to its strong hemolytic
activity and the ease to genetically manipulate
Escherichia coli, the -hemolytic HlyA of E. coli is
the RTX toxin first discovered and best studied. In
particular, the E. coli HlyAwas used as a model to
study the stoichiometry of the transmembrane pore
and its mechanism of formation (Ludwig et al.,
1993), and the mechanisms of ATPase-driven type I
secretion of HlyB and HlyD in interaction with the
host bacterium outer membrane protein TolC (An-
dersen et al., 2000; Balakrishnan et al., 2001; Tha-
nabalu et al., 1998). Awell detailed comprehensive
and critical review on basic molecular aspects of
  Genetic organisation and structure of RTX toxins. This figure represents the most common genetic and structural organisation of
RTX toxins and is mainly based on that of the E. coli HlyA (Hughes et al., 1992b; Ludwig et al., 1988). The genetic organisation of RTX toxins
is shown on the top. The four genes of the operon are represented by open boxes with the activator gene C, the gene encoding the structural
toxin A, and the secretion genes B and D. The dashed line below the gene map shows the direction of transcription. The rho-independent
transcription termination signal between the A and B gene is indicated by a hairpin. The gene products with their major structural
characteristics are represented below the corresponding genes. The domains of the structural toxin protein are annotated. GK indicates the
glycine-lysine acylation site(s). The ATP-binding cassette of the secretion protein B is abbreviated by ABC. N indicates the amino-terminal
and C the carboxy-terminal end of the peptides.
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structure and function of RTX toxins and their in
vivo function in cell killing has recently been
published (Welch, 2001).
RTX toxins are particularly widespread among
species of Pasteurellaceae. This family of bacteria
comprises evolutionary closely related bacteria
which are found mainly in animals and also in
man, either as commensals or as pathogens causing
similar types of infectious diseases affectingmucosal
tissue (Donachie et al., 1995). The current review
intends to give an overview on the occurrence and
the spread of RTX toxins in species of Pasteurella-
ceae, to summarize their phenotypes and to discuss
their potential role in pathogenesis and host speci-
ficity.
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Based on their genetic relationship, as calculated
from similarity analysis of the genes encoding the
structural toxin A, RTX toxins of Pasteurellaceae
can be grouped into four clusters (Fig. 2). These
clusters also reflect some of the main in vitro
phenotypes of these toxins, including hemolysis
and co-hemolysis (CAMP reaction) as well as
cytotoxic activity (Table 1).
The first cluster of RTX toxin genes is formed by
ApxIA ofA. pleuropneumoniae (Frey et al., 1993), a
pig pathogen causing pleuropneumonia, the toxin
LtxA (also named AaltA) of Actinobacillus actino-
mycetemcomitans causing juvenile periodontitis in
human (Lally et al., 1989a) and the hemolysinHlyA
of Escherichia coli which is found in human
uropathogenic E. coli isolates as well as in pig
isolates from various diseases in particular oedema
disease (Fig. 2). All these RTX toxins are reported to
possess strong cytotoxic activity. ApxIA and HlyA
are also strongly hemolytic on medium containing
sheep erythrocytes, while LtxA does not show
hemolysis on this medium. Although the structural
genes of these three RTX toxins show strong
similarities of their nucleotide sequences, the bac-
terial species harboring these three related RTX
toxins are phylogenetically distant from each other.
Escherichia coli, belonging to the Enterobacteria-
ceae, is not even a member of the Pasteurellaceae
(Fig. 2). This indicates that a horizontal transfer of
RTX toxin genes has occurred not only among
different species of Pasteurellaceae but also across
bacterial families.
  A. Phylogenetic relationship of structural RTX toxin genes from Pasteurellaceae and E. coli. B. Phylogenetic position of the bacterial
species harbouring the corresponding RTX toxin genes (indicated in brackets), based on the 16S rRNA gene (rrs) sequence of the type strains.
A distance matrix was calculated by the Jukes-Cantor algorithm (Jukes and Cantor, 1969) and a tree was built by the neighbour-joining
method (Saitou and Nei, 1987). Bootstrap values of 500 simulations are given at the branching points of the tree. Scale bars indicate genetic
distances.
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The second cluster of RTX toxins of Pasteurella-
ceae currently includes only two toxins, ApxIIIA of
A. pleuropneumoniae (Frey et al., 1993; Rycroft
et al., 1991) and PaxA of Pasteurella aerogenes
(Kuhnert et al., 2000). These two toxins are non-
hemolytic, but they both show a significant CAMP
reaction, a co-hemolytic reaction specified by the
synergy of certain pore-forming toxins and the
sphingomyelinase from -hemolytic Staphylococcus
aureus (Frey et al., 1994b; Kuhnert et al., 2000).
ApxIIIA was shown to be highly cytotoxic against
macrophages and was therefore previously also
named macrophage toxin (Lally et al., 1989b;
Macdonald and Rycroft, 1992; Rycroft et al.,
1991). The cytotoxic activity of PaxA has not yet
been analyzed. The bacterial species harboring these
two very similar toxins are phylogenetically distant
species of Pasteurellaceae, which is a further indica-
tion of a horizontal transfer of RTX toxin genes in
the past.
The third cluster contains the most prominent
representative of RTX toxins of Pasteurellaceae, the
leukotoxin LktA (Lo et al., 1987) of Mannheimia
(Pasteurella) haemolytica, as well as the leukotoxin
PlktA ofMannheimia varigena, the ApxIIA toxin of
A. pleuropneumoniae and AqxA of Actinobacillus
equuli. LktA plays a role in the pathogenesis of
bovine and ovine pneumonic pasteurellosis caused
by M. haemolytica (Frank, 1989; Gilmour and
Gilmour, 1989). Ten different alleles of the lktA
gene are currently known. They are derived fromM.
haemolytica,Mannheimia glucosida andPasteurella
trehalosi. These alleles have a mosaic structure
reflecting horizontal gene transfer and extensive
intragenic recombination which is thought to have
contributed to host switching and host specificity of
the different subtypes of M. haemolytica from
bovine and ovine hosts (Davies et al., 2001). The
leukotoxin PlktA of Mannheimia varigena, a por-
cine pathogen previously designated as Pasteurella
haemolytica-like organism (Chang et al., 1993a),
and the ApxIIA toxin of Actinobacillus pleuropneu-
moniae (Frey et al., 1993), the etiological agent of
porcine pleuropneumonia, are genetically close
relatives to LktA. ApxIIA is also found in Actinoba-
cillus suis andActinobacillus rossii, in variant forms
(Burrows and Lo, 1992; Schaller et al., 2000). The
recently discovered RTX toxin AqxA of Actinoba-
cillus equuli and Actinobacillus equuli-like bacteria
from horses (P. Kuhnert, unpublished results) be-
  Characteristics of selected RTX toxins.
Toxin mol. mass genetic locus host species current phenotypic
characterization
toxin specificity/
pathogen
specificity
Reference
HlyA 107 kDa hlyCABD E. coli strong haemolytic
strong cytotoxic
pores in lipid bilayers
nd*/human (Felmlee et al. , 1985)
ApxIA 110 kDa apxICABD A. pleuropneumoniae
A. suis
A. lignieresii
strong haemolytic
strong cytotoxic
CAMP
pores in lipid bilayers
nd/pig (Frey et al. , 1994a)
LtxA (AaltA ) 108 kDa ltxCABD
(altCABD)
A. actinomycetem-
comitans
leukotoxic human, higher
primates/human
(Kraig et al. , 1990)
ApxIIIA 113 kDa apxIIICABD A. pleuropneumoniae
A. rossii
cytotoxic
macrophage toxic
pores in lipid bilayers
CAMP
nd/pig (Chang et al. , 1993b)
PaxA 108 kDa paxCABD P. aerogenes
P. mairi
CAMP nd/pig (Kuhnert et al. , 2000)
ApxIIA 110 kDa apxIICA A. pleuropneumoniae
A. suis
A. rossii
Actinobacillus sp.
weak hemolytic
weak cytotoxic
pores in lipid bilayers
CAMP
nd/pig (Chang et al. , 1989)
LktA 102 kDa lktCABD M. haemolytica hemolytic
leukotoxic
cattle/cattle (Lo et al. , 1987)
PlktA 105 kDa plktCABD M. varigena hemolytic
leukotoxic
nd/pig (Chang et al. , 1993a)
AqxA 110 kDa aqxCABD A. equuli
A. equuli-like
hemolytic
CAMP
nd/horse (Berthoud et al. , 2002)
ApxIVA 170 ±202 kDa apxIVA A. pleuropneumoniae CAMP nd/pig (Schaller et al. , 1999)
* nd, not defined
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longs to the same phylogenetic cluster (Fig. 2). All
RTX toxins of this cluster showmoderate hemolytic
activity under in vitro conditions, and most of them
were confirmed to possess cytotoxic activity to-
wards cell cultures.
The toxin ApxIVof A. pleuropneumoniae (Schal-
ler et al., 1999) is genetically verydistant fromanyof
the other known RTX toxins (Fig. 2). It is not
expressed by A. pleuropneumoniae under culture
conditions, but is produced during infection of pigs
with A. pleuropneumoniae. ApxIVA can be ex-
pressed as recombinant protein in E. coli, where it
shows a slight hemolytic activity and a distinct co-
hemolytic CAMP reaction. The genetic organization
of apxIV also shows strong differences to the other
RTX toxins. It lacks the activator gene C and type I
secretion genes B and D. However, upstream
apxIVA an ORF was discovered, which is necessary
for the hemolytic and CAMP activity of the ApxIVA
toxin (Schaller et al., 1999). ApxIVA, which is
specific to the species A. pleuropneumoniae (Schal-
ler et al., 2001), shows high similarity to the RTX
protein FrpC of Neisseria meningitidis, a protein
that induces high levels of serum antibodies during
invasive disease (Osicka et al., 2001).
   	  
The role of RTX toxins in the pathogenicity of
pasteurellosis has been studied for a few species
either indirectly by molecular epidemiological in-
vestigations, by in vitro experiments of purified
toxins on cultured host cells, or directly by experi-
mental infection of animals with isogenic strains
where the corresponding toxin gene was deleted.
The leukotoxin LktA of M. haemolytica was inves-
tigated intensively. Purified LktA was shown to
induce the release of histamine from bovine pul-
monary mast cells (Adusu et al., 1994), to cause cell
swelling and rapid leakage of K from isolated
bovine neutrophils (Clinkenbeard et al., 1989) and
to cause increased synthesis of leukotriene B-4,
accompanied by neutrophil lysis (Clinkenbeard
et al., 1994). Makeswaran et al. (1992) observed
that culture supernatants ofM. haemolytica, which
contained LktA, stimulated an immediate neutro-
phil respiratory burst, asmeasured by the generation
of oxygen-derived free radicals. LktA was demon-
strated to bind to beta-2 integrins on sensitive bovine
leukocytes, very likely via CD18 (Ambagala et al.,
1999) (Jeyaseelan et al., 2000; Leite et al., 2000),
and it very rapidly leads to processes of apoptosis,
including DNA fragmentation (Stevens and Czu-
prynski, 1996; Sun et al., 1999). Deletion mutants
(lktA) of M. haemolytica revealed reduction in
virulence compared to their isogenic wild-type
strains, but were not avirulent, as measured by
clinical symptoms and lung lesion scores in an
experimentally infected calf model of pneumonic
pasteurellosis (Tatum et al., 1998). Consequently,
LktA is involved in pathogenicity ofM.haemolytica,
but it does not seem to be essential for the cause of
the disease.
The leukotoxin LtxA (AaltA) of A. actinomyce-
temcomitans was also demonstrated to bind beta-2
integrin of human target cells (Lally et al., 1997) and
to be able to kill human HL-60 by inducing
apoptosis (Korostoff et al., 1998). It is believed
that the elimination of acute inflammatory cells by
LtxA plays a critical role in the pathogenesis of
periodontitis caused byA. actinomycetemcomitans.
Differences in thepromoters of ltxA genes, due to the
presence or the absence of a 530-bp segment in
different strains, are responsible for low, respectively
high expression strains of LtxA (Brogan et al.,
1994). However, this significant difference of LtxA
production does not seem to be related to the
severeness of periodontitis in the patient fromwhom
the strains were isolated (Contreras et al., 2000),
and hence questions the impact of this toxin in
pathogenesis.
The role of the different Apx toxins of A.
pleuropneumoniae in the pathogenesis of porcine
pleuropneumonia was studied with deletion mu-
tants in the apx toxin genes and in trans-comple-
mentation experiments. Using the highly virulent A.
pleuropneumoniae serotype 1 type strain 4074,
which produces and secretes ApxIA and ApxIIA,
Jansen and collaborators showed that the parent
strain or thosemutants that secreted either ApxIA or
ApxIIA provoked an oxidative burst and killed
porcine neutrophils, whereas double mutants
(apxIA  apxIIA) did not (Jansen et al., 1995).
Direct evidence for the role of ApxIA and ApxIIA in
the pathogenesis of porcine pleuropneumonia was
obtained from experimental infection of pigs with
either a virulent strain JM5 ofA. pleuropneumoniae
serotype 5 or several derivatives of the same. The
wild-type strain JM5 secreted ApxIA and ApxIIA
andwas fully virulent.A deletionmutant,whichwas
unable to secrete ApxIA and ApxIIA, was non-
pathogenic for experimentally infected pigs. Re-
introduction of the genes allowing secretion of
ApxIIA resulted in a strain of moderate virulence,
while complementation with all genes for biosyn-
thesis and secretion of ApxIA and ApxIIA restored
full virulence. This showed that ApxIIA is essential
in the pathogenesis of porcine pleuropneumonia and
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that the combination of secreted ApxIA and ApxIIA
by certain serotypes of A. pleuropneumoniae is
responsible for the very severe symptoms and the
mostly fatal course of the disease (Reimer et al.,
1995). These results were confirmed by intratra-
cheal infusion of purified toxins ApxIA and ApxIIA
to pigs (Kamp et al., 1997). Antibodies directed
against ApxIA, ApxIIA and ApxIIIAwere shown to
neutralize the hemolytic and cytotoxic activities of
these toxins (Udeze and Kadis, 1992) and to protect
mice against experimental infection with A. pleuro-
pneumoniae (Bhatia et al., 1991). Finally, inactivat-
ed ApxIA, ApxIIA and ApxIIIA were shown to
confer protective immunity against A. pleuropneu-
moniae to pigs and were used as antigens in potent
vaccines (Kobisch and van den Bosch, 1992; van den
Bosch et al., 1990). Although ApxIA and ApxIIA
were shown to be essential virulence factors of A.
pleuropneumoniae, it should be noted that Actino-
bacillus suis and Actinobacillus rossii, both species
of low pathogenicity that are occasionally isolated
from pigs, particularly from early weaned piglets,
also secrete ApxIA and ApxIIA or ApxIIA and
ApxIIIA, respectively (Burrows and Lo, 1992;
Schaller et al., 2000). Consequently, ApxIA, ApxIIA
and ApxIIIA do not seem to be sufficient for
pathogenicity of A. pleuropneumonie. It has to be
determined whether the A. pleuropneumoniae-spe-
cific ApxIV toxin might be the crucial factor that
distinguishes this species as a significant pathogen
from the various related Actinobacillus species that
are not primary pathogens.
The role in pathogenicity of the RTX toxin PaxA,
which is produced by certain strains of Pasteurella
aerogenes and Pasteurella mairi, has not yet been
investigated in detail. However, P. aerogenes and P.
mairi, which were isolated from abortion or neona-
tal septicemia of pigs, always produced PaxA.
Contrary to this, strains from other samples, where
these species were found as opportunistic pathogens
or as commensals, were devoid of the paxA gene
(Kuhnert et al., 2000) (P. Kuhnert, unpublished
results), thus indicating that PaxA would be neces-
sary for P. aerogenes and P. mairi to cause systemic
infections.
The role of the recently discovered AqxA in the
virulence of the equine pathogen A. equuli and
related strains remains to be elucidated. This RTX
toxin is only present in certain A. equuli and A.
equuli-like isolates from horses and is not found in
others, indicating that it might contribute to infec-
tivity or persistence in the host.Nevertheless, there is
no clear evidence for a correlation of the presence of
AqxA and the pathogenicity of A. equuli until now.
Moreover, hemolytic A. equuli, also referred to as
Bisgaard Taxon 11, is reported to be commonly
detected as part of the bacterial flora of horses
(Bisgaard et al., 1984).
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The most apparent phenotype of RTX toxins is the
hemolytic or co-hemolytic (CAMP) activity mani-
fested by cultivating the corresponding bacteria on
standard nutrient blood agar which generally con-
tains sheep erythrocytes. Consequently, the hemo-
lytic activity of RTX toxins shows no species
specificity. The cytotoxic activity of some RTX
toxins, however, was shown to be specific for cells of
the host species of the correspondingpathogen.Thus
LtxA of the human pathogen A. actinomycetemco-
mitans kills specifically human and higher primate
monomyelocytes (Lally et al., 1989a), while LktA of
M. haemolytica, which causes bovine disease, kills
bovine lymphoid cells (Forestier and Welch, 1991;
Sun et al., 1999). Using recombinant chimeric ltxA/
lktA toxin genes allowed to determine the critical
area of the A. actinomycetemcomitans LtxA toxin
for recognition of human target cells which was
located in the segment containing the glycine-rich
nonapeptide repeats (Lally et al., 1994).
The E. coli hemolysin HlyA was shown to be
cytolytic to sheep erythrocytes, BL3 bovine leuke-
mia-derived B-lymphocytes and human B-cell lym-
phoma cells Raji. In contrast, the M. haemolytica
LktA leukotoxin only lyses bovine BL3 cells of the
three above-named cell types. Hybrid constructs
between the hlyA and the lktA genes allowed to
determine the domain of HlyA responsible for the
hemolytic activity and the domain of LktA that
determines the specificity for ruminant cells (Fores-
tier and Welch, 1991). Most recent studies on the
RTX toxin ligand-LFA-1 receptor interactions of
LtxA and LktA led to speculations that sequence
divergence among RTX toxins and the CD11a and
CD18 subunits as receptors might account for the
different host specificities observed for certain RTX
toxins (Jeyaseelan et al., 2000; Lally et al., 1997;
Welch, 2001).
Although there are no molecular data on the host
specificity of most of the RTX toxins from animal
pathogens except for LktA, epidemiological con-
siderations indicate host specificity for other RTX
toxins, too. In this respect it is interesting to compare
the pig pathogen A. suis and the horse-specific A.
equuli which is associated to sleepy foal disease.
Both A. suis and A. equuli are phylogenetically very
closely related Pasteurellaceae, based on sequence
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analyses of their identical rrs (16S rRNA) genes and
other housekeeping genes (Dewhirst et al., 1992) (P.
Kuhnert, unpublished results). Analysis of a large
number of A. suis isolates from pigs revealed
specifically the presence of apxICABDvar.suis and
apxIICAvar.suis genes and correspondingly the pro-
duction of ApxIA and ApxIIA (VanOstaaijen et al.,
1997). In contrast, hemolytic A. equuli and A.
equuli-like bacteria isolated from horses specifically
contained the aqxCABD operon of the newly
discovered AqxA toxin (P. Kuhnert, unpublished
results). This indicates that ApxIA and ApxIIA
contribute to the host specificity for pigs of A. suis,
A. pleuropneumoniae andA. rossii, which belong to
different phylogenetic subgroups of Actinobacillus.
In contrast,AqxA seems to direct the host specificity
of A. equuli and A. equuli-like bacteria in horses. It
has to be noted that hemolytic A. equuli were often
erroneously referred to as equine A. suis based on
their hemolytic phenotype which is not due to the
same RTX toxin (Bisgaard et al., 1984; Samitz and
Biberstein, 1991). The speculations which are de-
rived from molecular epidemiological observations,
however, must be confirmed further by in vitro
experimentswith specific equine and porcine cells or
in vivo experiments. For these purposes swapping of
correspondingRTXgenes fromA. suis andA. equuli
and testing in animalmodels the susceptibility of the
host for the corresponding wild-type or toxin-
recombinant strain could be considered.
! "#	
RTX toxins are found among a broad diversity of
Pasteurellaceae, mainly of the genus Actinobacillus,
Mannheimia andPasteurella.MostRTX toxin genes
exhibit a GC:AT ratio which ranges between 36%
and 46% GC and which is close to that of the
genomes of Pasteurellaceae (around 40%GC). This
indicates that RTX toxin genesmight originate from
ancestral Pasteurellaceae species from where they
spread also to other bacterial families during evolu-
tion (see also (Welch, 1991)).
Although RTX toxins might act as virulence
factors of several pathogens, they seem inmost cases
not to be essential for pathogenicity of these species.
While they might contribute significantly to the
severeness of the diseases caused by their host
bacteria, in many cases they appear to act together
with other virulence determinants. Moreover, the
occurrence of specific RTX toxins in species of low
pathogenicity or even avirulent species shows that
the virulence potential of a bacterium is not given by
the presence of an RTX toxin alone.
Currently, the most detailed results on the mo-
lecular mechanisms have been obtained on RTX
toxins the impact of which in pathogenicity of their
respective host bacterium is not very strong. It seems
therefore worthwhile to consider also more detailed
molecular studies of thoseRTXtoxinswhich seem to
play a crucial role in the virulence of their host
pathogens. Furthermore, it is worthwhile to discuss
in the future an additional biological role of RTX
toxins, which is their putative potential to drive or
determine host-specificity of the pathogen.
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